DOSE OF REALITY: BIOSIMILAR COMPETITION GENERATES SIGNIFICANT SAVINGS FOR PATIENTS AND THE U.S. HEALTH CARE SYSTEM
May 2, 2024
Reports Find Biosimilars Have Lower Prices Than Brand Name Biologics… Read More
© 2024 CSRXP- All Rights Reserved
Dose of Reality
DOSE OF REALITY: NEW ANALYSES UNDERSCORE HOW BIG PHARMA’S EGREGIOUS PRICING OF WEIGHT LOSS DRUGS IS UNSUSTAINABLE
Apr 25, 2024
Two Reports Explore Cost for U.S. Patients and the U.S. Health Care System of… Read More
Dose of Reality: CBO Confirms Big Pharma’s Egregious Prices on Weight Loss Drugs Are Unsustainable
Mar 22, 2024
CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings… Read More
DOSE OF REALITY: BIG PHARMA CEOS FACE A RECKONING FROM LAWMAKERS AND EXPERTS ON ANTI-COMPETITIVE PRACTICES AND PRICE GOUGING
Feb 12, 2024
Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices… Read More
DOSE OF REALITY: BIG PHARMA BUILDING PATENT THICKETS DISCONNECTED FROM ACTUAL INNOVATION TO CREATE NEW MONOPOLIES ON GLP-1 WEIGHT LOSS DRUGS
Feb 8, 2024
JAMA Analysis Finds Patents for Active Ingredients for Weight Loss Drugs… Read More
DOSE OF REALITY: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS DRIVE HIGHER HEALTH CARE COSTS
Jan 30, 2024
Big Pharma Price Hikes, Rising Launch Prices And Patent Abuse Impose Massive… Read More
DOSE OF REALITY: BIG PHARMA’S R&D INVESTMENTS DISCREDIT DOOM AND GLOOM INNOVATION RHETORIC
Jan 5, 2024
Report Finds Big Pharma Increased Spending on R&D in First Half of 2023,… Read More
DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART V: BIG PHARMA’S DEBUNKED INNOVATION RHETORIC
Jan 1, 2024
Big Pharma Discredited Its Own Bogus Rhetoric on Research and Development in… Read More
DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART IV: TAX AVOIDANCE SCHEMES AND KICKBACKS
Dec 29, 2023
Big Pharma’s Tax Avoidance Schemes and Use of Kickbacks to Boost Profits… Read More
DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART III: BIG PHARMA’S ANTI-COMPETITIVE TACTICS
Dec 28, 2023
Exploring the Cost of Big Pharma’s Egregious Abuse of the Patent System With… Read More
DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART II: BIG PHARMA’S BIG BLAME GAME, DTC, AND M&A SPENDING
Dec 27, 2023
Big Pharma’s Year of Big Spending Attempting to Evade Responsibility for… Read More
DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART I: BIG PHARMA’S EGREGIOUS PRICING PRACTICES
Dec 26, 2023
Take a Look Back on Big Pharma’s Year of Price Hikes And Skyrocketing Launch… Read More